[go: up one dir, main page]

HUP0002472A2 - Izolált dendritikus sejtmembrán-fehérje gének - Google Patents

Izolált dendritikus sejtmembrán-fehérje gének

Info

Publication number
HUP0002472A2
HUP0002472A2 HU0002472A HUP0002472A HUP0002472A2 HU P0002472 A2 HUP0002472 A2 HU P0002472A2 HU 0002472 A HU0002472 A HU 0002472A HU P0002472 A HUP0002472 A HU P0002472A HU P0002472 A2 HUP0002472 A2 HU P0002472A2
Authority
HU
Hungary
Prior art keywords
cell membrane
dendritic cell
proteins
membrane protein
protein genes
Prior art date
Application number
HU0002472A
Other languages
English (en)
Inventor
Elizabeth Esther Mary Bates
John Ford
Serge J.E. Lebecque
Odile Ravel
Sem Saeland
Jenny Valladeau
Original Assignee
Schering Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp. filed Critical Schering Corp.
Publication of HUP0002472A2 publication Critical patent/HUP0002472A2/hu
Publication of HUP0002472A3 publication Critical patent/HUP0002472A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A találmány tárgyát különböző emlős dendritikus sejtmembrán- fehérjék(DCMP-k) képezik, amelyek hasonlóságot mutatnak lektinek egyosztályával és aszialo-glikoprotein receptorokkal. A találmányfelöleli nevezett fehérjék agonistáit és antagonistáit, például atermészetes szekvenciák mutánsait, fúziós fehérjéket, kémiaihasonmásokat, antitesteket és egyéb szerkezeti vagy funkciósanalógokat. Szintén a találmány tárgyát képezik a találmány szerintifehérjéket kódoló izolált gének. Ezen fehérje- vagynukleinsavkészítmények különböző alkalmazásai és ehhez kapcsolódókitek, reagensek - elsősorban az immunrendszer betegségeinekterápiájában - szintén a találmány oltalmi körébe tartoznak. Ó
HU0002472A 1997-07-09 1998-07-08 Isolated dendritic cell membrane protein genes HUP0002472A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5308097P 1997-07-09 1997-07-09
PCT/US1998/013436 WO1999002562A1 (en) 1997-07-09 1998-07-08 Isolated dendritic cell membrane protein genes

Publications (2)

Publication Number Publication Date
HUP0002472A2 true HUP0002472A2 (hu) 2000-10-28
HUP0002472A3 HUP0002472A3 (en) 2003-08-28

Family

ID=21981809

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002472A HUP0002472A3 (en) 1997-07-09 1998-07-08 Isolated dendritic cell membrane protein genes

Country Status (24)

Country Link
US (6) US6277959B1 (hu)
EP (2) EP0998496B1 (hu)
JP (2) JP2002509438A (hu)
KR (1) KR20010021597A (hu)
CN (2) CN1493597A (hu)
AR (1) AR014891A1 (hu)
AT (1) ATE397018T1 (hu)
AU (1) AU755279C (hu)
BR (1) BR9811675A (hu)
CA (1) CA2295308C (hu)
CO (1) CO4790156A1 (hu)
DE (1) DE69839555D1 (hu)
ES (1) ES2308808T3 (hu)
HK (1) HK1028249A1 (hu)
HU (1) HUP0002472A3 (hu)
ID (1) ID26517A (hu)
IL (1) IL133494A0 (hu)
NO (1) NO20000097L (hu)
NZ (1) NZ501777A (hu)
PE (1) PE96899A1 (hu)
PL (1) PL337942A1 (hu)
SK (1) SK252000A3 (hu)
WO (1) WO1999002562A1 (hu)
ZA (1) ZA986051B (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187131A1 (en) * 1995-01-31 2002-12-12 Daniel Hawiger Enhanced antigen delivery and modulation of the immune response therefrom
US20040258688A1 (en) * 1995-01-31 2004-12-23 Daniel Hawiger Enhanced antigen delivery and modulation of the immune response therefrom
WO1999047673A2 (en) * 1998-03-17 1999-09-23 Schering Corporation Isolated mammalian membrane protein genes and related reagents
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
JP5007007B2 (ja) * 1999-11-15 2012-08-22 ミルテニイ バイオテック ゲゼルシャフト ミット ベシュレンクテル ハフツング 樹状細胞に特異的な抗原結合フラグメント、その組成物および使用方法、それによって認識される抗原およびそれによって得られる細胞
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
NZ534864A (en) * 2000-05-08 2006-04-28 Celldex Therapeutics Inc Human monoclonal antibodies to dentritic cells
JP2005505285A (ja) * 2001-10-09 2005-02-24 イミュネックス・コーポレーション 哺乳動物ｃ型レクチン
US20060008807A1 (en) * 2002-08-23 2006-01-12 O'hara Shawn M Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
EP1594533B1 (en) * 2003-01-31 2012-04-11 Celldex Research Corporation Antibody vaccine conjugates and uses therefor
US9259459B2 (en) * 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
US7547760B2 (en) * 2006-07-03 2009-06-16 West Virginia University Peptides and chemical compound for inhibition of SHP2 function
AU2014240262B2 (en) * 2007-02-02 2016-04-28 Baylor Research Institute Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)
NZ578696A (en) 2007-02-02 2012-01-12 Baylor Res Inst Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells
TWI422594B (zh) 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
NZ585556A (en) 2007-11-07 2012-07-27 Celldex Therapeutics Inc Antibodies that bind human dendritic and epithelial cell 205 (dec-205)
WO2011105424A1 (ja) * 2010-02-23 2011-09-01 国立大学法人東京大学 樹状細胞免疫受容体刺激剤
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
AU2015258875B2 (en) 2014-05-16 2020-12-24 Baylor Research Institute Methods and compositions for treating autoimmune and inflammatory conditions
CN108314740B (zh) * 2018-03-07 2024-02-27 上海晶诺生物科技有限公司 一种蛋白固定化修饰的细胞培养容器

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2046920B1 (hu) 1969-06-19 1974-05-03 Citizen Watch Co Ltd
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists

Also Published As

Publication number Publication date
IL133494A0 (en) 2001-04-30
ID26517A (id) 2001-01-11
HUP0002472A3 (en) 2003-08-28
US20020165346A1 (en) 2002-11-07
EP1980573A2 (en) 2008-10-15
US20060074234A1 (en) 2006-04-06
PE96899A1 (es) 1999-10-05
BR9811675A (pt) 2000-09-19
ZA986051B (en) 1999-01-18
US6756478B2 (en) 2004-06-29
US7691373B2 (en) 2010-04-06
AU8271298A (en) 1999-02-08
CN100391973C (zh) 2008-06-04
PL337942A1 (en) 2000-09-11
WO1999002562A1 (en) 1999-01-21
CN1493597A (zh) 2004-05-05
US20110244513A1 (en) 2011-10-06
ES2308808T3 (es) 2008-12-01
CA2295308A1 (en) 1999-01-21
US20040192892A1 (en) 2004-09-30
NO20000097L (no) 2000-03-09
CO4790156A1 (es) 1999-05-31
AR014891A1 (es) 2001-04-11
KR20010021597A (ko) 2001-03-15
HK1028249A1 (en) 2001-02-09
US7179467B2 (en) 2007-02-20
EP0998496A1 (en) 2000-05-10
CN1262689A (zh) 2000-08-09
NZ501777A (en) 2001-10-26
CA2295308C (en) 2010-12-14
SK252000A3 (en) 2000-09-12
US7034137B2 (en) 2006-04-25
JP2002509438A (ja) 2002-03-26
US6277959B1 (en) 2001-08-21
JP2008264000A (ja) 2008-11-06
US20070116703A1 (en) 2007-05-24
EP1980573A3 (en) 2009-06-10
EP0998496B1 (en) 2008-05-28
ATE397018T1 (de) 2008-06-15
DE69839555D1 (de) 2008-07-10
AU755279C (en) 2004-02-19
AU755279B2 (en) 2002-12-05
NO20000097D0 (no) 2000-01-07

Similar Documents

Publication Publication Date Title
HUP0002472A2 (hu) Izolált dendritikus sejtmembrán-fehérje gének
Südhof et al. Cassette of eight exons shared by genes for LDL receptor and EGF precursor
Bulinski et al. Peptide antibody specific for the amino terminus of skeletal muscle alpha-actin.
FI913637A0 (fi) Foer epitelceller specifik dna kodande vaextfaktor.
ATE371727T1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
DE68928137D1 (de) Dopamin-rezeptoren und gene
DE69132671D1 (de) Protein-g-gekoppelte glutaminsäure-rezeptoren
DK1218751T3 (da) Cöliakidiagnose under anvendelse af et gliadinepitop
DE69632536D1 (de) Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren
AR004860A1 (es) Anticuerpos mono o policionales, anticuerpos conjugados, o sus fragmentos, su utilizacion y metodo de diagnostico in vitro de patologias correlacionadas con una expresion anormal del receptor de la il-13, a partir de muestras biologicas susceptibles de contener el receptor de la il-13 expresado a un nivel anormal
Haefliger et al. Amphibian albumins as members of the albumin, alpha-fetoprotein, vitamin D-binding protein multigene family
FI864798A0 (fi) Menetelmä fuusioproteiinien valmistamiseksi sekä menetelmän toteuttamisessa käytettäviä tuotteita
HK1006854A1 (en) Nucleic acid encoding a t-cell antigen receptor polypeptide
ES2000278A6 (es) Procedimiento para preparar una proteina de fusion y para preparar una proteina eucariotica.
BR1100650A (pt) Proteìnas de superfìcie cd44 variantes, sequências de dna que as codificam, anticorpos contra estas proteìnas, bem como a sua utilização no diagnóstico e na terapia
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
Birchmeier Cytoskeleton structure and function
ATE419358T1 (de) Gebrauchsverfaheren eines neuen lysyloxidase- verwandten proteins
ES2072928T3 (es) Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
Aronstein et al. Identification of species-specific and gender-specific proteins and glycoproteins of three human schistosomes
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
WO2000039149A3 (en) Secreted proteins and uses thereof
DE3877136D1 (de) Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung.
NO178504C (no) Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat